多重用药作为评估老年人跌倒相关住院风险的简易指标
本研究基于魁北克综合慢性病监测系统构建人群队列,纳入2019年4月1日年龄>66岁、参保公共药物计划且前一年无跌倒相关住院的老年人,开发五种基于药物的指标,用性别分层Cox模型估计风险比并比较预测性能。结果显示所有指标预测性能相似,简单易得的多重用药指标可支持公共卫生监测。
要点
- 五种药物指标的风险比范围从1.43(≥1种潜在不适当药物,女性)到2.17(≥10种药物,男性)。
- 预测性能最低为≥1种潜在不适当药物(c统计量女性0.724、男性0.722),最高为≥1种增加跌倒风险药物(c统计量女性0.735、男性0.736)。
- 所有药物指标评估跌倒相关住院风险性能相似,多重用药等简单易得指标可支持公共卫生监测。
核心结论
- 所有基于药物的指标在评估跌倒相关住院风险方面性能相似;从公共卫生角度,具有简单易得额外优势的指标如多重用药可支持监测工作并为公共卫生行动提供信息。
研究设计与样本
- 基于魁北克综合慢性病监测系统构建的人群队列,纳入2019年4月1日(索引日期)年龄>66岁、参保公共药物计划且前一年无跌倒相关住院的个体,共647795名女性和529725名男性。
主要发现
- 风险比范围从≥1种潜在不适当药物(女性)的1.43(95%CI=1.37, 1.49)到≥10种药物(男性)的2.17(95%CI=2.05, 2.31)。
- 预测性能最低为≥1种潜在不适当药物(c统计量女性0.724、男性0.722),最高为≥1种增加跌倒风险药物(c统计量女性0.735、男性0.736)。
关键数值与推荐
- 五种药物指标:≥5种药物、≥10种药物、≥5个第三级解剖治疗化学分类、≥1种增加跌倒风险药物、≥1种潜在不适当药物均基于前一年平均索赔药物数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Medication is a modifiable risk factor for falls. Evaluating medication use may aid in identifying individuals at increased risk of a first fall and in preventing associated outcomes. The aim of this study was to identify the best medication-based measure to evaluate fall-related hospitalization risk among older adults. METHODS: A population-based cohort was created using the Quebec Integrated Chronic Disease Surveillance System. Individuals aged >66 on April 1, 2019 (index date) insured by the public drug plan and without fall-related hospitalization the prior year were included. Five medication-based measures were developed, derived from the average number of medications claimed in the previous year (≥5, ≥10 medications, ≥5 third-level Anatomical Therapeutic Chemical classes, ≥1 fall-risk increasing drugs, ≥1 potentially inappropriate medications). Hazard ratios were estimated with sex-stratified Cox models to predict fall-related hospitalization in the year after index date. Predictive performances were compared between each medication-based measure. RESULTS: The cohort included 647,795 women and 529,725 men. Hazard ratios ranged from 1.43 (95% CI=1.37, 1.49) for ≥1 potentially inappropriate medication (women) to 2.17 (95% CI=2.05, 2.31) for ≥10 medications (men). Lowest predictive performance was for ≥1 potentially inappropriate medication (c-statistic=0.724 [women]; 0.722 [men]), and highest predictive performance was for ≥1 fall-risk increasing drug (c-statistic=0.735 [women], 0.736 [men]). CONCLUSIONS: All medication-based measures have similar performance in assessing fall-related hospitalization. From a public health standpoint, measures that have the added benefits of being simple and accessible, such as polypharmacy, can support surveillance efforts and inform public health actions.
引用
- Gagnon ME, Talbot D, Simard M, et al. Polypharmacy as a Simple Measure for Assessing the Risk of Fall-Related Hospitalization in Older Adults. Am J Prev Med. 2025. PMID: 41344656. doi:10.1016/j.amepre.2025.108206
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。